Research Outputs (47)

Sort by: Date | Title

10 | 25 | 50 | 100

1/5

1 A C D E G H I K L M N O P R S T W All

15-Lipoxygenases and its metabolites 15(S)-HETE and 13(S)-HODE in the development of non-small cell lung cancer
Yuan HL, Li MY, Ma LT, Hsin MKY, Mok TSK, Underwood MJ, Chen GG ( 2010 )
THORAX
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1136/thx.2009.122747
Aberrant Concentrations of Liver-Derived Plasma Albumin mRNA in Liver Pathologies
Chan RWY, Wong J, Chan HLY, Mok TSK, Lo WYW, Lee V, To KF, Lai PBS, Rainer TH, Lo YMD, Chiu RWK ( 2010 )
CLINICAL CHEMISTRY
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1373/clinchem.2009.133355
Aberrant Promoter Methylation of DLEC1, a Critical 3p22 Tumor Suppressor for Renal Cell Carcinoma, is Associated With More Advanced Tumor Stage
Zhang QA, Ying JM, Li JS, Fan YC, Poon FF, Ng KM, Tao QA, Jin J ( 2010 )
JOURNAL OF UROLOGY
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1016/j.juro.2010.03.108
ACCELERATED FRACTIONATION RADIOTHERAPY AND LATE INTENSIFICATION WITH 2 INTRA-ARTERIAL CISPLATIN INFUSIONS FOR LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA
Yu KH, Yu SCH, Hui EP, Kam MKM, Vlantis AC, Yuen E, Chan ATC ( 2010 )
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1002/hed.21279
An RNA-directed nucleoside anti-metabolite, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd), elicits antitumor effect via TP53-induced Glycolysis and Apoptosis Regulator (TIGAR) downregulation
Lui VWY, Lau CPY, Cheung CSF, Ho K, Ng MHL, Cheng SH, Hong B, Tsao SW, Tsang CM, Lei KIK, Yamasaki Y, Mita A, Chan ATC ( 2010 )
BIOCHEMICAL PHARMACOLOGY
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1016/j.bcp.2010.02.012
Anticancer efficacy of 5F in NNK-induced lung cancer development of A/J mice and human lung cancer cells
Li MY, Leung J, Kong AWY, Liang NC, Wu KF, Hsin MKY, Deng YF, Gong XL, Lv YN, Mok TSK, Underwood MJ, Chen GG ( 2010 )
JOURNAL OF MOLECULAR MEDICINE-JMM
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1007/s00109-010-0676-4
A phase II study of fenretinide in patients with hormone refractory prostate cancer: a trial of the Cancer Therapeutics Research Group
Moore MM, Stockler M, Lim R, Mok TSK, Millward M, Boyer MJ ( 2010 )
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1007/s00280-009-1228-x
A sensitive and specific liquid chromatography-tandem mass spectrometric method for determination of belinostat in plasma from liver cancer patients
Wang LZ, Chan D, Yeo W, Wan SC, Chan S, Chan A, Lee SC, Lee HS, Goh BC ( 2010 )
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1016/j.jchromb.2010.07.015
A small molecule inhibitor of NF-kappa B, dehydroxymethylepoxyquinomicin (DHMEQ), suppresses growth and invasion of nasopharyngeal carcinoma (NPC) cells
Wong JHT, Lui VWY, Umezawa K, Ho Y, Wong EYL, Ng MHL, Cheng SH, Tsang CM, Tsao SW, Chan ATC ( 2010 )
CANCER LETTERS
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1016/j.canlet.2009.05.022
CD44 activation in mature B-cell malignancies by a novel recurrent IGH translocation
Hu XT, Chen YW, Liang ACT, Au WY, Wong KY, Wan TSK, Wong MLY, Shen LJ, Chan KK, Guo TH, Chu KM, Tao Q, Chim CS, Loong F, Choi WWL, Lu LW, So CC, Chan LC, Kwong YL, Liang RHS, Srivastava G ( 2010 )
BLOOD
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1182/blood-2009-09-238782

10 | 25 | 50 | 100

1/5

Research Outputs (47)

Share Link

Our policy towards the use of cookies